Subclinical atherosclerosis in ankylosing spondylitis: Is there a role for inflammation?;Aterosclerose subclínica em pacientes com espondilite anquilosante: Há um papel para a inflamação?

Revista Brasileira de Reumatologia

Volumn 53, Issue 5, 2013, Pages 377-381

  Valente, Renato Leandro Mattar ^a   Valente, Jamil Mattar ^a   de Castro, Gláucio Ricardo Werner ^a   Zimmermann, Adriana Fontes ^a   Fialho, Sonia Cristina de Magalhães Souza ^a   Pereira, Ivânio Alves ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Ankylosing spondylitis; Cardiovascular risk; Subclinical atherosclerosis

Indexed keywords

GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL CIRCUMFERENCE; ADULT; ADVENTITIA; ANKYLOSING SPONDYLITIS; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMMON CAROTID ARTERY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; GENDER; HUMAN; HYPERTENSION; LIPID ANALYSIS; MALE; MEDICAL HISTORY; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; ATHEROSCLEROSIS; COMPLICATION; CROSS-SECTIONAL STUDY; INFLAMMATION;

ADULT; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; PREVALENCE; SPONDYLITIS, ANKYLOSING;

EID: 84891674130     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042013000500002     Document Type: Article

References (25)

1. Braun J, Pincus T. Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol. 2002;20(Suppl. 28):S16-S22.
2. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26(Suppl.51):S35-S61.
3. Zochling J, Braun J. Mortality in ankylosing spondylitis. Clin Exp Rheumatol. 2008;26(Suppl.51):S80-S84.
4. Kaprover E, Little AH, Graham DC, Rosen PS. Ankylosing spondylitis: survival in men with and without radiotherapy. Arthritis Rheum. 1980;23:57-61.
5. Khan MA, Khan MK, Kushner I. Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol. 1981;8:86-90.
6. LehtinenK. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993;52:174-6.
7. Radford EP, Doll R, Smith PG. Mortality among patients with ankylosing spondylitis not given x-ray therapy. N Engl J Med. 1977;297:572-6.
8. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167-72.
9. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008;121Suppl:S21-S31.
10. O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002;90:18L-21L.
11. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens. 2002;20:2317-25.
12. Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der Horst-Bruinsma IE, et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol. 2010;37(1):161-6.
13. Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, et al. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore). 2009;88(6):358-65.
14. Mathieu S, Joly H, Baron G, Tournadre A, Dubost J, Ristori JM, et al. Trend towards increased arterial stiffness or intimamedia thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology. 2008;47(8):1203-7.
15. Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine. 2008;75:548-53.
16. Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La MG. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710-4.
17. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology. 2006;45:283-6
18. Capkin E, Kiris A, Karkucak M, Durmus I, Gokmen F, Cansu A, et al Investigation of effects of different treatment modalities on structural and functional vessel wall properties in patients with ankylosing spondylitis. Joint Bone Spine. 2011;78(4):378-82.
19. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modifi cation of the New York criteria. Arthritis Rheum 1984;27(4):361-8.
20. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining low "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957-63.
21. Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La MG. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710-4.
22. Ferrante A, GiardinaAR, Ciccia F, Parrinello G, LicataG, Giardina E, et al. Long-term anti-tumor necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int. 2009;30(2):193-8.
23. Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, et al. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol. 2006;33:2440-6.
24. Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-Tumor necrosis factor-a treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184-7.
25. Hermann F, Forster A, Chenevard R, Enseleit F, Hürlimann D, Corti, et al. Sinvastatin improves endothelial function in patients with rheumatoid arthritis. J Am Coll Cardiol. 2005;45:461-4.